Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATURN: Statins Use in Intracerebral Hemorrhage Patients
NCT03936361Phase 3Recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jun 2020
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in intracerebral hemorrhage (ICH) (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Recurrent symptomatic intracerebral hemorrhage at 24 months. Started Jun 2020; status: recruiting.
02
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03936361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03936361.